2004
DOI: 10.1016/j.patbio.2004.07.030
|View full text |Cite
|
Sign up to set email alerts
|

Évaluation de deux trousses commerciales EIA pour le diagnostic de l’hépatite C dans les conditions d’un laboratoire de virologie

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2006
2006
2020
2020

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 13 publications
0
1
0
Order By: Relevance
“…Both assays detect antibodies directed against the same viral proteins (core, NS3, NS4), except that AxSYM also contains a recombinant antigen derived from NS5. Both assays were shown to have good sensitivities and specificities (Zachary et al, 2004). In a direct comparison of three commercially available EIAs including AxSYM and Monolisa Plus, Monolisa Plus was the most specific, although the differences were not significant (Zachary et al, 2005).…”
Section: Resultsmentioning
confidence: 98%
“…Both assays detect antibodies directed against the same viral proteins (core, NS3, NS4), except that AxSYM also contains a recombinant antigen derived from NS5. Both assays were shown to have good sensitivities and specificities (Zachary et al, 2004). In a direct comparison of three commercially available EIAs including AxSYM and Monolisa Plus, Monolisa Plus was the most specific, although the differences were not significant (Zachary et al, 2005).…”
Section: Resultsmentioning
confidence: 98%